Cladribine Use in Relapsing Multiple Sclerosis After 8-10 Years: Two Case Reports of Patients From the ORACLE-MS

Miguel Angel Hernandez1, Rossana Abreu Rodriguez1, Yessica Contreras Martin1

  • 1Neurology, Multiple Sclerosis Unit, University Hospital Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, ESP.

Cureus
|December 30, 2024
PubMed
Summary

Two relapsing multiple sclerosis (MS) patients achieved long-term disease remission with a second course of cladribine, an immune reconstitution therapy. This real-world evidence supports cladribine